Trial intelligence / Profile preview

PK and Tolerance of Voriconazole in Healthy Subjects

NCT05330000Phase 1Completed

Sponsor
The Affiliated Hospital of Qingdao University
Start
May 2020
Primary completion
Jul 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised trial of voriconazole in fungal infection (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration, Area Under the Curve from time 0 to infinity and 2 more. Started May 2020; status: completed.

02

Drugs

voriconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT05330000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05330000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call